The latest health news
The air in Mexico City was once so toxic that people watched as dead birds fell out of the sky. In 1992, the United Nations declared the city the most …
Read More
The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. The drug, called Leqembi, was developed by …
Read More
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug Administration and Biogen to chronicle how a controversial Alzheimer’s disease drug was approved, and how …
Read More
Eisai’s announcement that lecanemab, its antibody drug for Alzheimer’s disease that targets the buildup of amyloid protein in the brain, modestly slowed cognitive decline in a Phase 3 trial offers …
Read More
The brains of Black adults in the U.S. age more quickly than those of white and Hispanic adults, showing features linked to Alzheimer’s disease and other dementias as early as …
Read More
At first glance, it might appear that better access to so-called amyloid-PET scans could compensate for some of the racial inequities in Alzheimer’s disease, as Linda Goler Blount called for …
Read More
Read in English | Leer en inglés. HARLINGEN, Texas — Aquí en el Valle del Río Grande casi todo el mundo conoce, o cuida, a alguien con demencia. No es …
Read More
Read in English | Leer en inglés. BROWNSVILLE, Texas — Gladys Maestre está en una misión de exploración. La investigadora del Alzheimer está conduciendo por Southmost, un barrio mexicano-americano justo …
Read More
While many Americans are familiar with the devastating impact of Alzheimer’s disease, few understand the cruel disparity with which it strikes. Black Americans are twice as likely to be diagnosed …
Read More